The Memorial Hospital of Salem County joins the Jefferson Neuroscience Network

MANNINGTON TWP. — The Memorial Hospital of Salem County (MHSC) has joined the Jefferson Neuroscience Network (JNN).

Through this collaboration, JNN and MHSC will provide some of the most sophisticated care and expertise available to patients with time-sensitive neurovascular diseases.

The Memorial Hospital of Salem County (MHSC) has joined the Jefferson Neuroscience Network (JNN).

“Participating in the Jefferson Neuroscience Network helps to ensure that our stroke patients at The Memorial Hospital of Salem County have access to the most advanced care,” says Susan Lotkowski, D.O., stroke director for MHSC.

By joining the network, MHSC offers patients access to the resources of JNN’s comprehensive stroke center, including community education programs, clinical trials and advanced protocols for the detection and treatment of stroke and other neuroscience disorders.

“This affiliation with JNN will mean a great deal to Salem County and surrounding communities,” said Richard Grogan, interim chief executive officer, MHSC. “Jefferson Hospital for the Neurosciences is nationally known for its stroke diagnosis, treatment and education, and we are proud to bring this affiliation to our area.”

Jefferson Hospital for Neuroscience is the region’s only dedicated hospital for neuroscience and the leading center for diagnosis and treatment of stroke and cerebrovascular disease.

Certain drugs for stroke must be administered within four-and-a-half hours for best chance of recovery. Neurologic procedures to repair AVMs and aneurysms are similarly urgent.

“Stroke is the third-leading cause of death in the United States, but the leading cause of disability,” says Rodney Bell, M.D., neurologist and co-director of the Jefferson Stroke Center. “On average, someone suffers a stroke every 45 seconds; someone dies of a stroke every three minutes.”

JNN places all of Jefferson’s resources, including vascular neurologists, dual-trained neurosurgeons, advanced technology, clinical trials in which they partner with the National Institutes of Health and community education about neuroscience issues, at the disposal of patients and physicians from hospitals participating in JNN.